/R E P E A T -- Media Advisory - Announcement of a multi-million dollar expansion of personalized medicine platform to New Brunswick/

MONCTON, NB, April 13, 2016 /CNW Telbec/ - Members of the media are invited to attend an important announcement regarding a multi-million dollar investment that will strengthen New Brunswick's personalized medicine capabilities and extend Exactis Innovation's network to Atlantic Canada.

Government officials, research institute representatives and industry leaders will be coming together on April 18 at 11:00 a.m. to announce this collaborative partnership that will help drive new breakthroughs in the field of cancer research.

DETAILS:
What:	Press conference announcing a multi-million dollar investment in New Brunswick
Who:	The Honourable Brian Gallant, Premier, New Brunswick The Honourable Victor Boudreau, Minister of Health, New Brunswick Mr. Chirfi Guindo, President and Managing Director, Merck Canada Inc. Mr. Andy Chabot, President and CEO, Cancer Research Society (CRS) Dr. Bruno Battistini, President and CEO – Scientific Director, New Brunswick Health Research Foundation (NBHRF) Dr. Gerald Batist, Co-Founder and Scientific Director of Exactis Innovation and Q-CROC, and Director, Segal Cancer Centre at the Jewish General Hospital Dr. Rodney Ouellette, President and Scientific Director, Atlantic Cancer Research Institute (ACRI)
When:	Monday, April 18, 2016 11:00 a.m.
Where:	Dr. Georges-L.-Dumont University Hospital Centre  Terrasse B, 2^nd floor 330 Université Ave. Moncton, NB  E1C 2Z3

SOURCE Merck Canada Inc.

Jane Bardsley, Office: 506-672-1860 extension 8334, Cell: 506-333-5164, [email protected]